Purpose
To develop a deployable, long-acting GLP-2 therapeutic delivered via patch to improve gut function, nutrient absorption, and oral vaccine response in infants, children and adult affected by environmental enteric dysfunction in LMICs.
Grantee
Division
Global Health
Date
JUNE 2026
Region served
GLOBAL
Committed amount
$3,302,000
Grant topic
Discovery and Translational Sciences,
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
12
Grantee location
Short Hills, New Jersey, United States
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.